Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Masumi, Ichinose"'
Autor:
Yasuyuki Kamada, Koya Hida, Haruaki Ishibashi, Shouzou Sako, Akiyoshi Mizumoto, Masumi Ichinose, Naveen Padmanabhan, Shinya Yoshida, Yutaka Yonemura
Publikováno v:
World Journal of Surgical Oncology, Vol 19, Iss 1, Pp 1-13 (2021)
Abstract Background Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) improves survival in selected patients with peritoneal metastasis (PM) from colorectal cancer (CRC). However, little has been reported on
Externí odkaz:
https://doaj.org/article/3b086c2fb297499dbcb939e8046ae9b3
Autor:
Aruna Prabhu, Andreas Brandl, Satoshi Wakama, Shouzou Sako, Haruaki Ishibashi, Akiyoshi Mizumoto, Nobuyuki Takao, Kousuke Noguchi, Shunsuke Motoi, Masumi Ichinose, Yang Liu, Yutaka Yonemura
Publikováno v:
Cancers, Vol 12, Iss 9, p 2536 (2020)
Signet ring cell subtype (SRC) of colorectal cancer (CRC) is a rare subtype and occurs in approximately 1% of all patients with CRC. Patients with peritoneal metastasis (PM) of SRC have a poor prognosis, and this subtype is frequently considered as a
Externí odkaz:
https://doaj.org/article/839fb69f074d4d0d9036055c8902acb4
Autor:
Aruna Prabhu, Andreas Brandl, Satoshi Wakama, Shouzou Sako, Haruaki Ishibashi, Akiyoshi Mizumoto, Nobuyuki Takao, Kousuke Noguchi, Shunsuke Motoi, Masumi Ichinose, Yang Liu, Yutaka Yonemura
Publikováno v:
Cancers, Vol 12, Iss 8, p 2212 (2020)
Neoadjuvant intravenous chemotherapy in patients with pseudomyxoma peritonei (PMP) has not shown convincing results. The effectiveness of neoadjuvant intraperitoneal (IP) chemotherapy has never been reported. This prospective, non-randomized phase II
Externí odkaz:
https://doaj.org/article/c36ef5398444417b9d543519aee16d9a
Autor:
Yutaka Yonemura, Aruna Prabhu, Shouzou Sako, Haruaki Ishibashi, Akiyoshi Mizumoto, Nobuyuki Takao, Masumi Ichinose, Shunsuke Motoi, Yang Liu, Kazurou Nishihara, Andreas Brandl, Sachio Fushida
Publikováno v:
Cancers, Vol 12, Iss 1, p 116 (2020)
The present study demonstrated prognostic factors for long-term survival in patients after a comprehensive treatment (CHT) for peritoneal metastasis (PM) from gastric cancer (GC). Materials and Methods: Among 419 patients treated with neoadjuvant int
Externí odkaz:
https://doaj.org/article/088f4e0abe6a47fb96655dc8f288407a
Autor:
Shouzou Sako, Nobuyuki Takao, Yang Liu, Shunsuke Motoi, Yutaka Yonemura, Yasuyuki Kamada, Haruaki Iahibashi, Akiyoshi Mizumoto, Satoshi Wakama, Masumi Ichinose, Kazurou Nishihara
Publikováno v:
Expert Opinion on Pharmacotherapy. 21:2057-2066
A new treatment strategy involving cytoreductive surgery (CRS) combined with perioperative intraperitoneal (IP) chemotherapy was proposed in 1999 by the Peritoneal Surface Oncology Group International, and the strategy is now justified as a state-of-
Autor:
Akiyoshi Mizumoto, Aruna Prabhu, Nobuyuki Takao, Shunsuke Motoi, Yutaka Yonemura, Masumi Ichinose, Wakama Satoshi, Kazuo Nishihara, Shouzou Sako, Haruaki Ishibashi, Andreas Brandl, Yang Liu
Publikováno v:
Indian J Surg Oncol
Autor:
Masamitsu Hirano, Yutaka Yonemura, Akiyoshi Mizumoto, Masumi Ichinose, Nobuyuki Takao, Kohsuke Noguchi, Shunsuke Motoi
Publikováno v:
Nippon Daicho Komonbyo Gakkai Zasshi. 73:143-150
Autor:
Yutaka Yonemura, Yoshio Endo, Emel Canbay, Yang Liu, Haruaki Ishibashi, Akiyoshi Mizumoto, Masamitu Hirano, Yuuki Imazato, Nobuyuki Takao, Masumi Ichinose, Kousuke Noguchi, Yan Li, Satoshi Wakama, Kazuhiro Yamada, Koutarou Hatano, Hiroshi Shintani, Hiroyuki Yoshitake, Shun-ichiro Ogura
Publikováno v:
Cancers, Vol 9, Iss 3, p 23 (2017)
In the past, peritoneal metastasis (PM) was considered as a terminal stage of cancer. From the early 1990s, however, a new comprehensive treatment consisting of cytoreductive surgery and perioperative chemotherapy has been established to improve long
Externí odkaz:
https://doaj.org/article/19248d3c458742eba67281d1e4771a44
Autor:
Yutaka Yonemura, Shinya Yoshida, Akiyoshi Mizumoto, Naveen Padmanabhan, Masumi Ichinose, Haruaki Ishibashi, Shouzou Sako, Koya Hida, Yasuyuki Kamada
Publikováno v:
World Journal of Surgical Oncology
World Journal of Surgical Oncology, Vol 19, Iss 1, Pp 1-13 (2021)
World Journal of Surgical Oncology, Vol 19, Iss 1, Pp 1-13 (2021)
BackgroundCytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) improves survival in selected patients with peritoneal metastasis (PM) from colorectal cancer (CRC). However, little has been reported on characteri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2178c2adf8434c6809d0590422ca6208
https://doi.org/10.21203/rs.3.rs-104732/v1
https://doi.org/10.21203/rs.3.rs-104732/v1
Autor:
Yutaka Yonemura, Haruaki Ishibashi, Aruna Prabhu, Yang Liu, Nobuyuki Takao, Akiyoshi Mizumoto, Shunsuke Motoi, Shouzou Sako, Satoshi Wakama, Kousuke Noguchi, Masumi Ichinose, Andreas Brandl
Publikováno v:
Cancers, Vol 12, Iss 2536, p 2536 (2020)
Cancers
Cancers
Simple Summary Approximately 1% of all patients with colorectal cancer, and 15% of patients with peritoneal metastasized colorectal cancer present with the subtype of signet ring cell, which is associated with inferior oncological outcome and reduced